TAO, Ming,FRIETZE, William,MELONI, David J.,WENG, Lingkai,ZHOU, Jiacheng,PAN, Yongchun
申请号：
PH12019500770
公开号：
PH12019500770A1
申请日:
2019.04.10
申请国别(地区):
PH
年份:
2020
代理人:
摘要：
The present application is directed to processes and intermediates for making 4-({2-[(aminosulfonyl)amino]ethyl}amino)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide, which is an inhibitor of indoleamine 2,3-dioxygenase, useful in the treatment of cancer and other disorders.
